Brief: Bioaffinity Announces Validation Study For Lung Cancer Test
25/02/2026 13:43
Feb 25 (Reuters) - bioAffinity Technologies Inc BIAF.O: BIOAFFINITY TECHNOLOGIES ANNOUNCES VALIDATION STUDY WITH BROOKE ARMY MEDICAL CENTER TO EXPAND SAMPLE COLLECTION OPTIONS FOR THE CYPATH® LUNG NONINVASIVE EARLY DETECTION LUNG CANCER TEST Source text: ID:nBw1NWPLFa Further company coverage: BIAF.O (((( Reuters.briefs@thomsonreuters.com ;));))